Uterine pathology in transmasculine persons on testosterone: a retrospective multicenter case series

Add time:08/02/2019    Source:sciencedirect.com

BackgroundAs part of transition, transmasculine persons often use testosterone gender-affirming hormone therapy; however, there is limited data on its long-term effects. The impact of exogenous testosterone on uterine pathology remains unclear. While testosterone achieves amenorrhea in the majority of this population, persistence of abnormal uterine bleeding can be difficult to manage. Excess androgens in cisgender females are associated with pathologic uterine processes such as polycystic ovary syndrome, endometrial hyperplasia, or cancer. There are no guidelines for management of abnormal uterine bleeding or endometrial surveillance in this population.

We also recommend Trading Suppliers and Manufacturers of Testosterone isocaproate (cas 15262-86-9). Pls Click Website Link as below: cas 15262-86-9 suppliers

Prev:Implant Pellets I: Effects of Compression Pressure on In Vivo Dissolution of delmadinone (cas 15262-77-8) Acetate Pellets
Next:Acute toxicity and residue analysis of Cartap hydrochloride (cas 15263-52-2) pesticide: Toxicological implications on the fingerlings of fresh water fish Labeo rohita)